Myogenic tone (MT), a fundamental stretch-sensitive vasoconstrictor property of resistance arteries and veins, is a key determinant of local blood flow regulation. We evaluated the pathways involved in MT development. The role of the RhoA/Rho kinase, p38 MAP kinase and HSP27 in MT was investigated in the rabbit facial vein, previously shown to possess MT at a pressure level equivalent to 20mmHg. Indeed, venous MT is poorly understood, although venous diseases affect a large proportion of the population. Stretched facial veins are characterized by a temperature-sensitive MT, which is normal at 39°C but fails to develop at 33°C. This allows for the discrimination of the pathways involved in MT from the multiple pathways activated by stretch. Isolated vein segments were mounted in organ baths and stretched. Temperature was then set at 33°C or 39°C. MT was associated to the translocation of RhoA to the plasma membrane and the Rho kinase inhibitor Y27632 decreased stretchinduced MT by 93.1±4.9%. MT was also associated to an increase in p38 (131,0±12,5% at 39°C versus 100% at 33°C) and HSP27 phosphorylation (196.1±13,3% versus 100%) and the p38 MAP kinase inhibitor SB203580 decreased MT by 36.5±8.1%. (39°C, compared to RFV stretched at 33°C). Finally, phosphorylation of p38 was blocked by Y27632 and Hsp27 phosphorylation was inhibited by SB203580 and Y27632.
Introduction
The process of matching blood flow to metabolic demand through changes in perfusion pressure is determined to a large extent by myogenic tone (MT). Myogenic properties of vessels include two processes: basal MT and myogenic response. Basal MT is a constant vasocontraction due to the transmural pressure or stretch applied to the arterial wall.
Myogenic response is characterized by a smooth muscle cells contraction in response to increase in pressure or stretch (1) . The myogenic response participates in the local regulation of blood flow and protects downstream capillary beds from large increases in hydrostatic pressure, such as that induced by postural changes, and a rise in the amplitude of MT is associated with hypertension (2) and diabetes mellitus (3) . Signaling mechanisms that contribute to MT require both calcium entry, protein kinase C and phospholipase C activation (4) as well as calcium-sensitization of the contractile apparatus (5-7). There is also growing evidence that actin polymerization and the dynamic remodeling of the actin cytoskeleton play an important role in MT (8) . In addition, Ca 2+ and myosin light chain (MLC) phosphorylation are key regulators of the dynamic reorganization of actin filaments. In recent years, evidence has accumulated that the ras-related small GTP binding protein Rho is another important signaling element that mediates various actin-dependent cytoskeletal functions, including smooth muscle contraction.
The role of mitogen-activated protein (MAP) kinases, which may also affect smooth muscle contractility (9) , in pressure myogenic contraction have not been fully explored (6) . Using the rabbit facial vein (RFV), we have previously shown that ERK1/2 activation, although stimulated by stretch, is not linked to MT (10) . In another study, in resistance arteries, we found that activation of p38 MAP kinase contributes to vascular smooth muscle contraction induced by thromboxane A2 (11) . Furthermore, it has been shown that endothelin-1 activates p38 MAP kinase pathways and heat shock protein (HSP) 27, and that p38 could regulate phosphorylation of HSP27 (12) . A specific role has been found for HSP27 in the regulation of actin cytoskeletal dynamics, based on the ability of HSP27 to modulate phosphorylation dependent actin polymerization (13). Thus we hypothesized that RhoA/Rho kinase and p38-Hsp27 might play a role in myogenic contraction.
Nevertheless, a main difficulty in studying MT, in addition to its location to small blood vessels, is that stretch per se activates multiple pathways not necessarily involved in MT.
Indeed, stretch and MT cannot easily be dissociated; classically, arteries submitted to pressure (thus developing MT due to stretch) are compared to unstretched arteries (absence of pressure). To bypass this difficulty, we used the RFV that develops MT to a degree similar to that observed in resistance arteries and which is highly temperature sensitive (5). At equal stretch, MT that is observed in the RFV at 39°C is absent at 33°C (5) . Using the RFV is also opening an important perspective in the understanding of vein pathophysiology. Indeed, the control of venous tone is poorly understood and sparsely studied. Venous tone changes with aging (14), hypertension (15) or diabetes (16) . MT occurs in the RFV with a stretch level (5mN in a 3-4 mm long segment) corresponding to a blood pressure approximately equal to 20 mmHg, which is within the normal range in veins. Thus, MT may play a role in venous tone regulation even though the system is operating at low pressures.
Therefore, we used the RFV model allowing the comparison of stretched vessels with (39°C) or without (33°C) MT, to test the hypothesis that p38, HSP27 or RhoA activation could be involved in or affected by the development of MT in RFV.
Materiel and Methods

Rabbit facial vein:
Buccal segments of the facial vein were isolated as previously described (5) from male New Zealand white rabbits (2.5-2.7 kg). The procedure used was in accordance with the European Community standards on the care and use of laboratory animals (authorization # 00577). Three mm-long ring segments of RFV were mounted between parallel stainless steel wires in 5ml organ baths. One wire was attached to a fixed support, while the other was connected to a moveable holder supporting a tension transducer, so that isometric force could be recorded and data was collected (Biopac MP 100, La Jolla, CA, USA). Vein segments were maintained at 33°C in a physiological salt solution (PSS) equilibrated at pH 7.4, pO 2 160 mmHg, pCO 2 37 mmHg (5).
Each segment was submitted to one of the following protocols:
1. RFV segments were stretched to 5.0 mN and allow to stabilize for 30 min, at 33°C.
2. RFV segments, maintained at 33°C or 39°C were exposed or not to one of the following agents (10 nmol/L to 10 µmol/L): the Rho kinase inhibitor Y27632 or the p38 MAP kinase inhibitor SB203580.
3. RFV were just bathed in PSS, without stretch, at 33°C or 39°C.
Four or five segments were obtained from each rabbit, so that vein segments from the same rabbit could be submitted to different experimental conditions. In each segment force was measured in one of the condition described above and immediately frozen for biochemical analysis, so that wall force and activation of p38, HSP27 or RhoA could be correlated.
P38 MAP kinase and HSP27 activation
Phosphorylation of p38 (phospho-p38) and HSP27 (phospho-HSP27) was quantified in RFV segments using Western-blot analysis. Tissue extraction was done as previously described 
Statistical Analysis
Results are expressed as mean ± SEM. The significance of the different treatments was determined by 2-factor ANOVA for repeated measures (comparison of concentrationresponse curves) or two-tailed Student's t-test. P values <0.05 were considered to be significant.
Results
In RFV segments MT developed at 39°C, whereas it was absent at 33°C (figure 1). As previously shown (5), after reducing temperature to 33°C, the addition of papaverine (10 µmol/L) does not further relax the vein (not shown).
In RFV at 39°C exposed to stretch, Y27632 induced a concentration-dependent reduction of MT (figure 1). SB203580 attenuated MT in a dose-dependent way but to lesser extent than The phosphorylation of p38-MAP kinase was determined in RFV maintained at 33°C or 39°C, with or without Y27632. The effect of temperature was also evaluated and basal p38 phosphorylation was considered to be 100% in unstretched RFV at 33°C. p38 phosphorylation was not affected by temperature in unstretched veins ( figure 4A ). At 33°C, stretch induced a significant increase of p38 phosphorylation (141.0±11.0%) compared with unstretched veins. This activation of p38 was not significantly prevented by Y27632 ( figure   4A ).
Then we measured p38 activation in the presence of stretch at 33°C (without MT) and at 39°C
(with MT). Basal p38 phosphorylation was considered to be 100% in vein segments stretched at 33°C. Stretch at 39°C was also associated to an increased in p38 phosphorylation (131.0±12.5%) and Y27632 completely blocked p38 phosphorylation associated with MT ( figure 4B ).
In another series of experiments, HSP27 phosphorylation was determined in RFV segments submitted or not to stretch at 33°C or 39°C and in the presence or absence of Y27632 (10 µmol/L) or SB203480 (10 µmol/L). In unstretched RFV segments the temperature had no significant effect on HSP27 phosphorylation ( fig.5A ). In stretched RFV segments maintained at 33°C, HSP27 phosphorylation was not different from that measured in unstretched segments at 33°C, and neither Y27632 nor SB239580 had an effect on HSP27
phosphorylation. Compared with stretched vein segments at 33°C, HSP27 phosphorylation was higher in stretched vein segments at 39°C and thus developing MT (196.1±13.3% of control, figure 5B ). Both SB203580 and Y27632 significantly inhibited HSP27
phosphorylation associated with MT.
Ponceau red staining, measured in each group was not significantly affected in the different experimental condition, suggesting that the blots were loading with similar amounts of proteins. In addition, the amount of actin was found to be similar in each group.
Discussion
This study shows that MT was associated to RhoA translocation from the cytosol to the plasma membrane and to Rho kinase activation. These results are consistent with a previous work showing that Y27632 caused a dose-dependent inhibition of basal tone in mesenteric resistance arteries (17) . In rat tail arteries Y27632 only partly attenuated MT (1). This discrepancy may reflect a difference in the degree of participation of Rho kinase in MT in different vessels (1) . It has been shown that a Ca 2+ sensitization may contribute to MT (18) , and recent evidence for the involvement of the small GTPase RhoA in Ca 2+ sensitization in smooth muscle contraction has been reported by several laboratories (18, 19) . Rho kinase, the Our results also indicate that p38 MAP kinase inhibition attenuated in part MT (30% maximal inhibition). In addition, p38 phosphorylation was higher in RFV segments developing MT.
Furthermore, our findings show that Y27632 inhibited contraction-induced p38 phosphorylation, suggesting that RhoA/Rho kinase activation was upstream of p38 and induced its activation. Our findings are consistent with a previous study suggesting that p38
MAP kinase activation could be involved in the mechanotransduction of wall tension in gracilis muscle arterioles (6) . Studies in large vessels and isolated smooth muscle cells suggested that MAP kinases activation contributes to vascular smooth muscle contraction induced by endothelin-1 (ET1) (21) and angiotensin II (22) . Some of the downstream events coupled with p38 MAP kinase activation include phosphorylation of MAPK-activated protein (MAPKAP) kinases 2 and 3, which in turn phosphorylate HSP27 (23) . Phosphorylation of HSP27 is another MAP kinase-mediated mechanism possibly modulating the contractile response of vascular smooth muscle (12) . We found that HSP27 was activated in the presence of MT and that RhoA and p38 were required for this activation. Nevertheless, that HSP27 is phosphorylated does not necessarily imply that it is directly involved in MT. Several reports suggest that HSP27 might modulate actin filament dynamics and be involved in contraction of smooth muscle cells. HSP27, in its non-phosphorylated state, behaves as a phosphorylationregulated-F-actin capping protein capable of inhibiting actin polymerization (24) .
Phosphorylation of HSP27, via activation of p38, might markedly modify the equilibrium in favor of polymerized actin, thereby contributing to the maintenance of the microfilament network. Studies in cells transiently transfected with dominant negative RhoA suggest that i)
RhoA might exert its effects on cytoskeleton reorganization through HSP 27 and ii) cytoskeletal proteins might interact to induce sustained smooth muscle contraction (25) . It is still unclear whether RhoA interacts with HSP27, but our work suggests that RhoA via the activation of Rho kinase might stimulate p38 leading to HSP27 phosphorylation.
It should be noted that we used a vein which may not be representative of resistance arteries, most usually used in the study of MT. Nevertheless, the RFV shares several common features with arteries, including histological features and a strong capacity to contract (5).
Nevertheless, each specific blood vessel (and this applies to arteries) has specific features and extrapolation must always be considered carefully. The RFV has this interesting feature allowing comparing stretched vessels with or without MT. This is a key issue of the present study as stretch per se activates many pathways not necessarily involved in MT, as we have previously shown with ERK1/2 (10). Of course, we cannot totally exclude that MT in the RFV does not rely on a highly temperature sensitive step in the process involved in MT.
Nevertheless, only myogenic tone can be turned off and on between 33 and 37°C whereas the other forms of tone are unaffected (angiotensin II, 5HT, KCl…). 
